High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy

BACKGROUND: Breast cancer is the most commonly diagnosed cancer worldwide. However, the well-known biomarkers are not enough to meet the needs of precision medicine. Novel targets are desirable and highly valuable for improved patient survival. In this regard, we identified complement component C7 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huikun, Zhao, Yawen, Liu, Xiaoli, Fu, Li, Gu, Feng, Ma, Yongjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497743/
https://www.ncbi.nlm.nih.gov/pubmed/34631552
http://dx.doi.org/10.3389/fonc.2021.724250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497743/
https://www.ncbi.nlm.nih.gov/pubmed/34631552
http://dx.doi.org/10.3389/fonc.2021.724250

Ejemplares similares